Related by context. All words. (Click for frequent words.) 64 Posaconazole 61 Significantly Reduced 61 divalproex sodium 61 SPRYCEL ® 61 APTIVUS r 60 severe hypersensitivity reactions 60 Certolizumab 60 symptomatic hyponatremia 59 ARCALYST ® 59 Alpha interferons including 59 Discontinuations 59 ocular adverse 59 hematologic adverse 59 sotalol 59 Neulasta ® 59 TEAEs 59 ARCOXIA 59 Adjuvant Treatment 59 VIIBRYD 58 RLAI 58 Dasatinib 58 Hepatotoxicity 58 ORENCIA ® 58 Ranolazine 58 discontinuations 58 discontinuations due 58 Ziprasidone 58 dalteparin 58 acitretin 58 alpha interferons 58 ALT flares 57 metformin accumulation 57 antiplatelet agent 57 hypomagnesemia 57 paroxetine sertraline 57 discontinuation 57 venlafaxine ER 57 alpha 2a 57 angiotensin converting enzyme inhibitor 57 Keppra R 57 rizatriptan 57 ANDA Filing 57 CIMZIA TM 57 NDA Submission 57 Pivotal Phase III 57 concomitant medications 57 Meets Primary Endpoint 57 PRISTIQ 57 Coadministration 57 Hypotension 57 BANZEL 57 ABC/3TC 57 bisoprolol 57 Losartan 57 ULORIC 57 FASLODEX 57 Known hypersensitivity 57 tumor lysis syndrome 57 venlafaxine Effexor 56 lacosamide 56 hematologic abnormalities 56 H2 antagonists 56 Investigational Treatment 56 Thrombocytopenia 56 prednisone prednisolone 56 Noxafil 56 PEGINTRON TM 56 events TEAEs 56 posaconazole 56 danazol 56 RISPERDAL 56 flutamide 56 NEUPOGEN 56 voriconazole 56 Phase III Clinical Trial 56 hematologic toxicity 56 sitaxsentan 56 Glimepiride 56 miconazole Lauriad ® 56 conventional DMARDs 56 peginterferon alfa 2b 56 XAGRID 56 events AEs 56 TMP SMX 56 Showed Significant 56 VIRAMUNE 56 Generic Version 56 LYSTEDA 56 peginterferon alfa 56 hallucinations dyskinesia 56 TDF FTC 56 LOVENOX R 56 ATACAND 56 arterial thromboembolic events 56 Infusion Reactions Severe 56 APTIVUS ritonavir 56 DOXIL 56 rFVIIa 56 Lamotrigine 56 darunavir r 56 Janssen Risperdal 56 salmeterol fluticasone 56 #mg BID [003] 56 angioedema 56 Adverse events 56 venous thromboembolic events 56 Serious ocular 56 Angioedema 56 dopamine partial agonist 56 CAELYX 56 thienopyridine 56 BYSTOLIC 55 ABILIFY R 55 nasopharyngitis 55 induce orthostatic hypotension 55 Neutropenia 55 concomitant AEDs 55 terfenadine 55 IXEMPRA 55 Non Responders 55 Ovidrel 55 Quetiapine 55 Peripheral edema 55 AGILECT R 55 febrile neutropenia 55 angioneurotic edema 55 BENICAR HCT 55 Cymbalta duloxetine 55 nitrofurantoin 55 Soriatane 55 Sycrest 55 GSK# [001] 55 mcg QD 55 Vfend 55 rasagiline tablets 55 Serious adverse reactions 55 MULTAQ 55 Helicobacter pylori eradication 55 Psoriasis Drug 55 neutropenia dehydration dyspnea 55 Valsartan 55 coadministration 55 Angiox ® 55 isoproterenol 55 moderate renal impairment 55 RAPTIVA 55 peripheral sensory neuropathy 55 treatment emergent adverse 55 EXJADE 55 Stent thrombosis 55 hepatotoxicity 55 oral vancomycin 55 mycophenolate mofetil 55 neutropenia thrombocytopenia 55 antiandrogen 55 infusional 55 desvenlafaxine succinate 55 systemic corticosteroids 55 Phase III Trial 55 HMG CoA reductase inhibitors 55 KETEK 55 #mg BID [001] 55 ketoconazole 55 TORISEL 55 Protease Inhibitors 55 capillary leak 55 Treatment discontinuations due 55 Pivotal Study 55 mg BID 55 phenelzine 55 mycophenolic acid 55 proton pump inhibitor PPI 55 PRADAXA 55 panitumumab Vectibix 55 Toxicities 55 SSRI SNRI 55 headache abdominal pain 55 pegaptanib 55 Glucophage metformin 55 Double Blind Randomized 55 Tardive dyskinesia 55 pyrexia mucositis sepsis febrile 54 zonisamide SR 54 RISPERDAL ® 54 Valacyclovir 54 Blood Pressure Drug 54 ribavirin therapy 54 tenofovir emtricitabine 54 oxycodone CR 54 elotuzumab 54 Cimzia TM 54 haematologic 54 anagrelide hydrochloride 54 Resubmission 54 thromboembolic events 54 tirofiban 54 abacavir Ziagen 54 Hepatic Impairment 54 Rhinocort 54 metastatic RCC 54 Fewer Side Effects 54 PDUFA Date 54 INVEGA ® 54 liver transaminases 54 MIRAPEX 54 Astepro 54 EFFEXOR XR 54 oral levofloxacin 54 CIMZIA 54 nonhematologic adverse reactions 54 VIBATIV 54 mg kg dose 54 aripiprazole Abilify 54 calcineurin inhibitor 54 concurrent ITP 54 Testosterone Gel 54 Desmopressin 54 Mirapexin 54 ddI 54 mcg BID 54 Bifeprunox 54 Cardiotoxicity 54 Adverse Effects 54 PENTASA 54 DMARDS 54 tizanidine 54 Discontinue 54 cholestyramine 54 Benazepril 54 arterial thromboembolic 54 COZAAR 54 hypersensitivity reaction 54 Generic Versions 54 anaphylactoid reactions 54 carbidopa levodopa 54 miconazole MBT 54 moderate hepatic impairment 54 DMARD 54 aspirin clopidogrel 54 Eltrombopag 54 Bicalutamide 54 diabetic gastroparesis 54 hematological parameters 54 renal impairment 54 LPV r 54 Peg IFN 54 Esomeprazole 54 fluoxetine paroxetine 54 corticosteroid therapy 54 TRIZIVIR 54 ribavirin RBV 54 virologic failure 54 VAPRISOL 54 Lupus Drug 54 Didanosine 54 Mg Uk 54 Kepivance 54 NOXAFIL 53 KAPIDEX 53 biologic DMARD 53 certolizumab 53 decitabine 53 ß blockers 53 Bupropion 53 fluvastatin Lescol 53 Rheumatoid Arthritis Drug 53 Pegylated Liposomal Doxorubicin 53 oxcarbazepine 53 Significantly Reduces 53 ipratropium bromide 53 plus COPEGUS 53 VFEND 53 FDA Approvals 53 CIMZIA TM certolizumab pegol 53 visilizumab 53 verapamil 53 Hypersensitivity reactions 53 JANUMET 53 Serious Adverse Events 53 ziprasidone 53 administered concomitantly 53 FOLPI 53 sargramostim 53 MEVACOR 53 antifibrinolytic 53 IIIa inhibitor 53 Melphalan 53 myopathy rhabdomyolysis 53 serotonin norepinephrine reuptake inhibitor 53 imiquimod cream 53 Tamsulosin 53 EGRIFTA TM tesamorelin 53 pharmacokinetic interactions 53 PROCRIT 53 hydroxymethyl coenzyme 53 Approvable 53 cholecystitis 53 neuroleptics 53 Prozac Paxil Zoloft 53 PROVIGIL 53 lenalidomide dexamethasone 53 ara C 53 gemtuzumab ozogamicin 53 tapentadol ER 53 clomipramine 53 potentially hepatotoxic 53 sitagliptin metformin 53 PEG IFN 53 propafenone 53 primidone 53 interstitial pneumonia 53 lactic acidosis 53 Desvenlafaxine Succinate 53 Aggrenox R 53 LAMICTAL 53 ACTOplus met XR 53 ONTAK 53 stent thromboses 53 aripiprazole 53 prophylactic antihistamines 53 acute bipolar mania 53 GnRH agonist 53 ARCALYST 53 parecoxib 53 Gout Drug 53 Elitek 53 anthracycline taxane 53 angiotensin converting enzyme inhibitors 53 LHRH agonists 53 thromboembolic 53 quetiapine 53 Expanded Indication 53 Boosts Survival 53 Optivar 53 thrombocytopenia neutropenia 53 Patient Enrollment 53 benazepril 53 acyclovir Lauriad R 53 hypersensitivity reactions 53 unstable angina pectoris 53 mCi kg 53 Teriflunomide 53 torsemide ER 53 renal toxicity 53 fatigue asthenia 53 duloxetine hydrochloride 53 mesylate 53 RAPAMUNE 53 tegaserod 53 eplerenone 53 Metoprolol 53 cisplatin gemcitabine 53 insulin detemir 53 HCV Genotype 53 #mg/m# [001] 52 dermatologic toxicities 52 4mg/kg 52 olmesartan 52 QTc prolongation 52 ONGLYZA ™ 52 endophthalmitis 52 INVEGA 52 periprocedural 52 REBETOL combination therapy 52 cytopenias 52 prospectively stratified 52 octreotide LAR 52 Hydralazine 52 IND Application 52 divalproex 52 tamsulosin 52 Orally Active 52 nasopharyngitis headache 52 hepatic dysfunction 52 renal insufficiency 52 piperacillin tazobactam 52 pruritis 52 Adverse reactions 52 Ischemic 52 estramustine 52 potassium sparing diuretics 52 PROMACTA 52 Certolizumab pegol 52 FROVA 52 anemia neutropenia 52 Celebrex celecoxib 52 ISTODAX 52 ritonavir boosted lopinavir 52 terazosin 52 TNF antagonist 52 dextromethorphan quinidine 52 Exacerbations 52 hematological toxicity 52 Megace 52 PEG INTRON 52 MARINOL R 52 ALTACE 52 enalapril 52 dose cytarabine 52 arthralgia 52 Respiratory Symptoms 52 HMG CoA reductase inhibitor 52 Raptiva ® 52 invasive aspergillosis 52 antidepressants fluoxetine 52 leucopenia 52 FDA Okays 52 DU #b 52 Diabetic Neuropathy 52 Perindopril 52 #mg QD [002] 52 Febrile neutropenia 52 Intrathecal 52 IV APAP 52 interferon gamma 1b 52 Migranal 52 Anti VEGF 52 EMSAM 52 fluvoxamine 52 Kaplan Meier estimates 52 AST ALT 52 mycophenolate mofetil MMF 52 Hematologic 52 rabeprazole 52 aspartate aminotransferase AST 52 retrograde ejaculation 52 Ticagrelor 52 adriamycin 52 alkylating agent 52 inhaled treprostinil 52 Hypocalcemia 52 goserelin 52 mometasone 52 #mg/day [002] 52 octreotide 52 Novel Inhibitor 52 headache nausea diarrhea 52 Milestone Payments 52 insulin secretagogue 52 Spectrum Pharmaceuticals Announces 52 Combo Therapy 52 Concomitant 52 headache nasopharyngitis 52 Torsades de Pointes 52 Zavesca ® 52 QTc intervals 52 hypercalcemia 52 recurrent ischemic 52 receiving XGEVA 52 transaminases 52 COPD Exacerbations 52 Gastrointestinal Stromal Tumors 52 Vimpat ® 52 tranylcypromine 52 gastrointestinal toxicities 52 UPLYSO 52 Reduced Risk 52 transaminase 52 abacavir lamivudine 52 rufinamide 52 urate lowering 52 β blockers 52 AMEVIVE 52 Serevent salmeterol 52 REVLIMID R 52 timolol 52 tipranavir r 52 alanine aminotransferase 52 laboratory abnormalities 52 Lactic acidosis 52 anticholinergic agents 52 palonosetron 52 Tiuxetan 52 rosiglitazone maleate 52 pegfilgrastim 52 hepatic adverse 52 LATUDA 52 TELINTRA 52 fosamprenavir 52 BROVANA 52 ADHD Medication 52 uric acid lowering 52 Lubiprostone 52 hepatic enzyme 52 patients receiving ERBITUX 52 aprepitant 52 somatostatin analog 52 Supplemental Biologics License Application 52 oral antidiabetic drugs 52 elevated plasma concentrations 51 agomelatine 51 gastrointestinal ulcers 51 beta 1a 51 coadministered 51 prolonged QT interval 51 propranolol Inderal 51 headache diarrhea nausea 51 lumiracoxib 51 efalizumab 51 extrapyramidal symptoms 51 Epilepsy Drug 51 bupropion SR 51 ischemic complications 51 HCl capsules 51 Aloxi injection 51 non metastatic osteosarcoma 51 Positive Opinion 51 nicardipine 51 Targretin capsules 51 TAXOTERE ® 51 ReFacto 51 Viread Emtriva 51 platelet inhibitor 51 thrombotic events 51 ABILIFY ® 51 Thal Dex 51 doxorubicin docetaxel 51 moderately emetogenic 51 Kaletra lopinavir ritonavir 51 Adjunctive 51 CYP #A# 51 neutropenia febrile neutropenia 51 Cyclosporine 51 Arixtra 51 tolterodine ER 51 balsalazide 51 PLAVIX 51 Aceon 51 Singulair montelukast 51 PRT# 51 GENERIC SILDENAFIL SOFT Generic 51 VIMOVO 51 CIMZIA ™ 51 antiarrhythmic 51 GRALISE 51 Zyban bupropion 51 PASI scores 51 conventional antipsychotics 51 DDAVP 51 unresectable HCC 51 cardiovascular ischemic 51 injectable formulations 51 GnRH agonists 51 febuxostat 51 torsade de pointes 51 nimodipine 51 Tenormin 51 AEs 51 PENNSAID 51 Osteoarthritis Pain 51 containing abacavir 51 antithrombotic agent 51 severe hypoglycemic 51 XGEVA 51 hypocalcemia 51 ileus 51 hypokalemia 51 Somatuline R Depot 51 Alphagan P 51 lispro 51 Benicar ® 51 lipid elevations 51 Antiarrhythmic 51 seropositive patients 51 Nifedipine 51 2A receptor agonist 51 neuroleptic 51 Cinacalcet HCl 51 Antiangiogenic 51 p = NS 51 MYLOTARG 51 paliperidone ER 51 FDA Panel Recommends 51 Schizophrenia Drug 51 Nuvion 51 infusion reactions 51 salmeterol HFA MDI 51 VELCADE melphalan 51 secondary hyperparathyroidism 51 Drug Fails 51 AVELOX 51 hematological adverse 51 sevelamer carbonate 51 Fluticasone Propionate 51 OPANA ER 51 Known generically 51 INTEGRILIN 51 nonsedating antihistamine 51 Treatment emergent adverse 51 Receptor Antagonist 51 Prostate Cancer Patients 51 cSSSI 51 Severe allergic reactions 51 AGILECT ® 51 Marketing Authorisation Application 51 nephrotoxicity 51 Recommends Approval 51 events thrombocytopenia neutropenia 51 R adalimumab 51 arbaclofen 51 galantamine 51 severe exacerbations 51 oral antidiabetes 51 SAEs 51 vernakalant hydrochloride 51 Granulocyte Colony Stimulating Factor 51 erythropoietic 51 CHOP chemotherapy 51 leukopenia 51 FOSRENOL ® 51 risperidone Risperdal 51 irbesartan 51 fibrinolytic 51 Submits NDA 51 lipid lowering agents 51 thyrotoxicosis 51 CsA 51 Fast Track Status 51 PROCRIT ® 51 anthracycline containing 51 cardiac toxicity 51 pancytopenia 51 ciclosporin 51 olanzapine quetiapine 51 olanzapine LAI 51 Febuxostat 51 incidence ≥ 51 heparin induced thrombocytopenia 51 muscarinic 51 sumatriptan succinate 51 tardive dyskinesia TD 51 hematologic parameters 51 bilateral renal artery 51 HPA axis suppression 51 aromatase inhibitor AI 51 prolactin elevation 51 Lupron Depot 51 Generic Version Of 51 Angiomax monotherapy 51 systemic hypotension 51 Inhaled Insulin 51 Eloxatin ® 51 nadolol 51 Generalised Anxiety Disorder 51 R imatinib mesylate 51 nephrotoxic 51 COPERNICUS 51 systemic corticosteroid 51 Million Milestone Payment 51 diarrhea dyspepsia 51 squalamine 51 INFERGEN 51 oxymorphone ER 50 Shingles Vaccine 50 strong CYP#A# inducers 50 ALT elevations 50 PegIFN RBV 50 LHRH analogues 50 Lipid Lowering 50 PULMICORT RESPULES 50 caspofungin 50 CHMP Opinion 50 QTc 50 hypercholesterolaemia 50 extrapyramidal disorder 50 TEMODAL 50 abrupt discontinuation 50 Hectorol R 50 COREG 50 FEMALES SHOULD BE ADVISED 50 Seroquel quetiapine 50 myelosuppression 50 lamotrigine 50 First Patient Enrolled 50 Severe hypersensitivity reactions 50 hyperammonemia 50 tinidazole 50 desvenlafaxine 50 volociximab 50 Kyowa Kirin 50 unfavorable cytogenetics 50 Erythropoietic therapies may 50 phenytoin 50 risedronate sodium tablets 50 GnRH antagonist 50 diarrhea nausea vomiting 50 venlafaxine 50 nefazodone 50 abacavir containing 50 transdermal fentanyl 50 antiarrhythmic drug 50 anagrelide 50 nateglinide 50 MAO inhibitor 50 β blocker 50 PSVT 50 catheter occlusion 50 pantoprazole 50 ACOMPLIA R 50 gastrointestinal toxicity 50 Veramyst 50 hepatic failure 50 prazosin 50 valdecoxib 50 reinfarction 50 lumiliximab 50 paliperidone 50 XOPENEX Inhalation Solution 50 IOP lowering 50 vidofludimus 50 hepatic insufficiency 50 KRAS mutant tumors 50 CIMZIA ® 50 Testosterone Patch 50 Data Suggest 50 hyperbilirubinemia 50 FDA Accepts 50 endometrial hyperplasia 50 Genzyme Myozyme 50 Novantrone 50 malignancy HCM 50 MCyR 50 Thrombotic events 50 cytopenia 50 ancrod 50 statin monotherapy 50 bolus dose 50 ACZ# 50 Dermatologic toxicities 50 bile acid sequestrant 50 ICD shocks 50 phentermine topiramate 50 recurrent glioblastoma multiforme 50 sulfonylurea metformin 50 acromegalic patients 50 liver enzymes ALT 50 AGGRASTAT R 50 EBMT criteria 50 indapamide 50 tumor necrosis 50 Evista raloxifene 50 neutropenia anemia 50 AVANDIA 50 paclitaxel carboplatin 50 Higher Doses 50 NUCYNTA ® 50 nocturnal hypoglycaemia 50 prolactin levels 50 baminercept 50 hydrochloride capsules 50 Receives Positive Opinion 50 Catapres 50 exocrine pancreatic insufficiency 50 pravastatin Pravachol 50 acetazolamide 50 neutropenic patients 50 gemifloxacin 50 didanosine associated 50 cisapride 50 diarrhea vomiting nausea 50 refractory gout 50 Gemifloxacin 50 delayed CINV 50 Q#IR 50 doxorubicin cyclophosphamide 50 elagolix 50 levalbuterol 50 Dacogen injection 50 Aldactone 50 QT interval prolongation 50 imipramine 50 iniparib BSI 50 Starlix 50 overdosage 50 thromboembolism 50 NUCYNTA R 50 Blood Pressure Reduction 50 eptifibatide 50 anticholinergic medication 50 Syndrome RLS 50 intracranial hemorrhage ICH 50 Pivotal Clinical Trial 50 antimuscarinic 50 AERx ® 50 Wellbutrin XL ® 50 calcium antagonist 50 anti thrombotic 50 anxiolytic 50 Seroquel quetiapine fumarate 50 transaminase elevations 50 serious cardiovascular thrombotic 50 ventricular fibrillation VF 50 ocrelizumab 50 eluting stent 50 R palivizumab 50 forodesine 50 aminotransferases 50 intravenous dosing 50 cerebral vasospasm 50 serum urate 50 #mg/day [001] 50 Dovonex 50 anaphylactoid reaction 50 Eraxis 50 subcutaneous ORENCIA 50 linaclotide treated 50 Fibrillex TM 50 Androxal TM 50 Telintra 50 Altoprev 50 prokinetic 50 BEACOPP 50 Dexilant 50 atorvastatin #mg 50 neutropenic sepsis 50 Indomethacin 50 OADs 50 KEFLEX 50 elevated ALT 50 sulfamethoxazole trimethoprim 50 somnolence dizziness 50 HIV lipodystrophy 50 SSRI antidepressant 49 ADVERSE EVENTS 49 zoledronate 49 ® bortezomib 49 symptomatic intracranial hemorrhage 49 akathisia 49 adrenal suppression 49 monotherapy 49 Phenoptin 49 peripheral edema 49 SPARLON 49 Emtriva Viread 49 EDARBI 49 cardiotoxic 49 IFN α 49 Liver Injury 49 continuous intravenous infusion 49 pamidronate 49 d4T 49 Blood Clot Risk 49 adenosine injection 49 del 5q MDS 49 hyperprolactinemia 49 containing LABAs 49 Pharmacokinetics PK 49 labetalol 49 Stronger Warnings 49 inhaled budesonide 49 Antiviral Activity 49 SPRIX ® 49 recurrent VTE 49 LUMIGAN R 49 POSIDUR TM 49 serum ALT 49 sustained ventricular tachycardia 49 gout flares 49 cidofovir 49 postoperative AF 49 Left Ventricular Hypertrophy 49 atazanavir 49 EVIZON TM 49 DLTs 49 Teveten 49 Intraocular Pressure 49 chronic idiopathic thrombocytopenic purpura 49 Weight Loss Drug 49 Cenestin 49 hyperkalemia 49 telithromycin 49 levocetirizine 49 Generic Lovenox 49 GHRH 49 Tofranil 49 hypoglycemic events 49 Non Invasive Treatment 49 Potentially Fatal 49 Amnesteem 49 titrated glipizide 49 Announces Tentative Approval 49 boosted protease inhibitor 49 Cipro XR 49 fondaparinux 49 limiting toxicity 49 nucleoside analog 49 mesilate 49 post herpetic neuralgia PHN 49 Diamyd Medical Diamyd 49 atacicept 49 concomitant cardiac 49 immunomodulatory therapy 49 CCyR 49 tiagabine 49 Fortovase 49 Kinase Inhibitor 49 anthracycline chemotherapy 49 Orphan Status 49 fenofibric acid 49 Zelapar 49 PROCHIEVE 49 Cleviprex TM clevidipine 49 suboptimal adherence 49 ritonavir boosted protease inhibitor 49 sodium nitroprusside 49 Thrombotic thromboembolic complications 49 fluoxetine Prozac 49 dopaminergic therapy 49 Paroxetine 49 Revlimid lenalidomide 49 protease inhibitors PIs 49 fluticasone propionate FP 49 Milestone Payment From 49 generalized tonic clonic seizures 49 TRISENOX 49 mg clopidogrel 49 ATV RTV 49 vasodilatation 49 Orphan Designation 49 antirheumatic 49 bone marrow fibrosis 49 nonadherence 49 Receptor Antagonists 49 5 lipoxygenase inhibitor 49 vasoactive 49 Receives Orphan Drug Designation 49 mitomycin C 49 nadroparin 49 INVEGA ™ 49 impaired renal 49 Hiberix 49 ZEGERID Capsules 49 deferiprone 49 venous thromboembolic disease 49 thalidomide dexamethasone 49 Delayed Release Tablets 49 TNF alpha inhibitor 49 Accelerated Approval 49 NPH insulin 49 hepatic enzymes 49 Lovastatin 49 treat dysmenorrhea 49 baseline HbA1c 49 ventricular tachycardia VT 49 Raptiva efalizumab 49 INTEGRILIN ® 49 Frova ® 49 sulphonylureas 49 Allegra fexofenadine 49 sensory neuropathy 49 Lipid Levels 49 Valdoxan 49 plus MTX 49 Serdolect ® 49 HBeAg positive 49 anaphylactic reactions bronchospasm 49 virologic response 49 Hemophilia B 49 QVA# 49 neutropaenia 49 EMEND 49 Thalomid ® 49 atherothrombotic events 49 neuroleptic malignant syndrome 49 hypocalcaemia 49 symptomatic hypotension 49 tumor regressions 49 RITUXAN 49 vasodilators 49 Xenazine ® 49 dizziness somnolence 49 Breast Cancer Incidence 49 Abelcet 49 taribavirin 49 amisulpride 49 gout flare 49 Prostate Cancer Vaccine 49 definite stent thrombosis 49 androgen suppression 49 juvenile myoclonic epilepsy 49 Depakene 49 interferon beta 1b 49 Begin Clinical Trials 49 hemoptysis 49 serotonin syndrome 49 fostamatinib 49 Effexor venlafaxine 49 ENTEREG ® 49 gemcitabine Gemzar ® 49 beclomethasone dipropionate 49 oral hypoglycemic agents 49 Actimmune R 49 inotropes 49 NATRECOR R 49 Xibrom TM 49 gastrointestinal adverse reactions 49 bosentan 49 colorectal carcinomas 49 Dextofisopam